HC Wainwright & Co. Reiterates Buy on Adicet Bio, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Adicet Bio (NASDAQ:ACET) and maintained a price target of $10.
May 15, 2024 | 4:46 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Adicet Bio and maintained a price target of $10, indicating continued confidence in the company's potential.
The reiteration of a Buy rating and maintenance of a $10 price target by a reputable analyst firm like HC Wainwright & Co. suggests strong confidence in Adicet Bio's future performance, likely leading to positive short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100